Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition

被引：52

作者：

Deng, Lei ^{[2
]}

Kiedrowski, Lesli A. ^{[3
]}

Ravera, Elizabeth ^{[1
]}

Cheng, Haiying ^{[1
]}

Halmos, Balazs ^{[1
]}

机构：

[1] Albert Einstein Coll Med, Montefiore Med Center, Dept Oncol, Bronx, NY 10461 USA

[2] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Med, Bronx, NY 10467 USA

[3] Guardant Hlth Inc, Redwood City, CA USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 09期

关键词：

MUTATIONS;

D O I：

10.1016/j.jtho.2018.04.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E169 / E172

页数：4

共 10 条

[1] TATTON Ph Ib Expansion Cohort: Osimertinib plus Savolitinib for Pts with EGFR-Mutant MET-Amplified NSCLC after Progression on Prior EGFR-TKI [J].

Ahn, M. ;

Han, J. ;

Sequist, L. ;

Cho, B. C. ;

Lee, J. S. ;

Kim, S. ;

Su, W. ;

Tsai, C. ;

Yang, J. C. ;

Yu, H. ;

Horn, L. ;

Lee, K. ;

Haddad, V. ;

Frigault, M. ;

Ahmed, G. ;

Yang, L. ;

Ghiorghiu, D. ;

Oxnard, G. .

JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) :S1768-S1768

[2] Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung Cancer [J].

Bahcall, Magda ;

Sim, Taebo ;

Paweletz, Cloud P. ;

Patel, Jyoti D. ;

Alden, Ryan S. ;

Kuang, Yanan ;

Sacher, Adrian G. ;

Kim, Nam Doo ;

Lydon, Christine A. ;

Awad, Mark M. ;

Jaklitsch, Michael T. ;

Sholl, Lynette M. ;

Jaenne, Pasi A. ;

Oxnard, Geoffrey R. .

CANCER DISCOVERY, 2016, 6 (12) :1334-1341

[3] Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients [J].

Chabon, Jacob J. ;

Simmons, Andrew D. ;

Lovejoy, Alexander F. ;

Esfahani, Mohammad S. ;

Newman, Aaron M. ;

Haringsma, Henry J. ;

Kurtz, David M. ;

Stehr, Henning ;

Scherer, Florian ;

Karlovich, Chris A. ;

Harding, Thomas C. ;

Durkin, Kathleen A. ;

Otterson, Gregory A. ;

Purcell, W. Thomas ;

Camidge, D. Ross ;

Goldman, Jonathan W. ;

Sequist, Lecia V. ;

Piotrowska, Zofia ;

Wakelee, Heather A. ;

Neal, Joel W. ;

Alizadeh, Ash A. ;

Diehn, Maximilian .

NATURE COMMUNICATIONS, 2016, 7

[4] Evaluation of hepatic impairment on pharmacokinetics and safety of crizotinib in patients with advanced cancer [J].

El-Khoueiry, Anthony B. ;

Sarantopoulos, John ;

O'Bryant, Cindy L. ;

Ciombor, Kristen K. ;

Xu, Huiping ;

O'Gorman, Melissa ;

Chakrabarti, Jayeta ;

Usari, Tiziana ;

El-Rayes, Bassel F. .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (04) :659-670

[5] Dramatic Response to. Combination Erlotinib and Crizotinib in a Patient with Advanced, EGFR-Mutant Lung Cancer Harboring De Novo MET Amplification [J].

Gainor, Justin F. ;

Niederst, Matthew J. ;

Lennerz, Jochen K. ;

Dagogo-Jack, Ibiayi ;

Stevens, Sara ;

Shaw, Alice T. ;

Sequist, Lecia V. ;

Engelman, Jeffrey A. .

JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (07) :E83-E85

[6] Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer [J].

Janakiraman, Manickam ;

Vakiani, Efsevia ;

Zeng, Zhaoshi ;

Pratilas, Christine A. ;

Taylor, Barry S. ;

Chitale, Dhananjay ;

Halilovic, Ensar ;

Wilson, Manda ;

Huberman, Kety ;

Ricarte Filho, Julio Cezar ;

Persaud, Yogindra ;

Levine, Douglas A. ;

Fagin, James A. ;

Jhanwar, Suresh C. ;

Mariadason, John M. ;

Lash, Alex ;

Ladanyi, Marc ;

Saltz, Leonard B. ;

Heguy, Adriana ;

Paty, Philip B. ;

Solit, David B. .

CANCER RESEARCH, 2010, 70 (14) :5901-5911

[7] Osimertinib and Cabozantinib Combinatorial Therapy in an EGFR-Mutant Lung Adenocarcinoma Patient with Multiple MET Secondary-Site Mutations after Resistance to Crizotinib [J].

Kang, Jin ;

Chen, Hua-Jun ;

Wang, Zheng ;

Liu, Jing ;

Li, Bing ;

Zhang, Tengfei ;

Yang, Zhenfan ;

Wu, Yi-Long ;

Yang, Jin-Ji .

JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) :E49-E53

[8] Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers [J].

Katayama, Ryohei ;

Shaw, Alice T. ;

Khan, Tahsin M. ;

Mino-Kenudson, Mari ;

Solomon, Benjamin J. ;

Halmos, Balazs ;

Jessop, Nicholas A. ;

Wain, John C. ;

Yeo, Alan Tien ;

Benes, Cyril ;

Drew, Lisa ;

Saeh, Jamal Carlos ;

Crosby, Katherine ;

Sequist, Lecia V. ;

Iafrate, A. John ;

Engelman, Jeffrey A. .

SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (120)

[9] Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non-Small Cell Lung Cancer [J].

Li, Anna ;

Yang, Jin-ji ;

Zhang, Xu-chao ;

Zhang, Zhou ;

Su, Jian ;

Gou, Lan-ying ;

Bai, Yu ;

Zhou, Qing ;

Yang, Zhenfan ;

Han Han-Zhang ;

Zhong, Wen-Zhao ;

Chuai, Shannon ;

Zhang, Qi ;

Xie, Zhi ;

Gao, Hongfei ;

Chen, Huajun ;

Wang, Zhen ;

Wang, Zheng ;

Yang, Xue-ning ;

Wang, Bin-chao ;

Gan, Bin ;

Chen, Zhi-hong ;

Jiang, Ben-yuan ;

Wu, Si-pei ;

Liu, Si-yang ;

Xu, Chong-rui ;

Wu, Yi-long .

CLINICAL CANCER RESEARCH, 2017, 23 (16) :4929-4937

[10]

York Emily R, 2017, J Thorac Oncol, V12, pe85, DOI 10.1016/j.jtho.2017.02.020

← 1 →